Andrew Leach is head of Chemical Biology and head of Industry Partnerships at EMBL-EBI. His team develops and manages ChEMBL, EMBL-EBI’s database of quantitative small-molecule bioactivity data focused in the area of drug discovery. The group is involved in various other collaborative projects such as Open Targets and Illuminating the Druggable Genome, both of which are concerned with target selection and prioritization.